ClinicalTrials.Veeva

Menu

Identification of Novel Markers of Human Lung Disease

The Ohio State University logo

The Ohio State University

Status

Withdrawn

Conditions

Lung Diseases, Interstitial

Treatments

Other: novel biomarkers of lung disease

Study type

Observational

Funder types

Other

Identifiers

NCT02369575
2014H0367

Details and patient eligibility

About

The purpose of this study is to investigate new therapies for advanced lung disease.

Full description

This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • any one on lung transplant list

Exclusion criteria

  • HIV positive

Trial contacts and locations

1

Loading...

Central trial contact

Megan Ballinger

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems